Trial intelligence / Profile preview

Immune response induced by BCG vaccination

NL-OMON37373Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Oct 2012
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Open-label, single-arm trial of bacillus calmette-guerin substrain danish 1331 live antigen in Tuberculosis (TB), sponsored by Leiden University Medical Center. Started Oct 2012; status: active, not recruiting.

02

Drugs

bacillus calmette-guerin substrain danish 1331 live antigen
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NL-OMON37373.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON37373.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call